IntegraGen
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5 Rue Henri Desbruères, Evry, Ile-de-Fra...Phone Number
+33 160910900Website
www.integragen.comRevenue
$13.4 MillionStock Symbol
ALINTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About IntegraGen
IntegraGen, founded in 2000, is a biotechnology company specializing in the genomics of cancer and rare genetic diseases. As part of the OncoDNA group, IntegraGen is a leading provider of DNA sequencing services and genomic data interpretation software. The company operates one of the largest next-generation sequencing laboratories in France and collaborates with prestigious research institutes. IntegraGen leverages advanced sequencing technology to deliver precision medicine solutions to patients. Headquartered in France with additional presence in the United States, the company provides biomarker testing and clinical interpretation tools that guide treatment and monitoring of late-stage solid tumors while also accelerating new cancer drug development. IntegraGen is publicly listed on Euronext Growth in Paris.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IntegraGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if IntegraGen has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when IntegraGen launches new products
Click to see if IntegraGen had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once IntegraGen has new funding data
Earning: See what the market has to say on IntegraGen recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at IntegraGen
Website visits: Recent activity has been detected on your website
IntegraGen, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if IntegraGen is spiking on competitors!
Recommended Actions
Find VP level buyers at IntegraGen
Find more new buyers
Company Profile Activity
Activity Insights
IntegraGen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
IntegraGen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about IntegraGen.
IntegraGen Tech Stack
A closer look at the technologies used by IntegraGen
See more technologies
Most Recent Scoops
Earnings
Sales
Left Company
Executive Move
Left Company
Left Company
Executive Move
IntegraGen News & Media
Succès de l’offre publique d’achat amicale initiée par OncoDNA sur les actions IntegraGen
GOSSELIES, Belgique--(BUSINESS WIRE)--Regulatory News: OncoDNA, société privée de technologies de la santé et de médecine de précision centrée sur l’oncologie, faisant suite à la communication officielle de l’Autorité des marchés financiers français (AMF) sur les résultats finaux de la transaction initiée en juillet dernier, a le plaisir d’annoncer le succès, au terme de la période de réouverture, de l’offre publique d’achat amicale visant les actions de la société IntegraGen (Paris:ALINT). ParRéouverture de l’offre publique d’achat amicale initiée par OncoDNA sur les actions IntegraGen, du 30 octobre au 12 novembre 2020, suite au succès de la première offre
GOSSELIES, Belgique & ÉVRY, France--(BUSINESS WIRE)--Regulatory News: OncoDNA SA et IntegraGen SA (Paris : ALINT) – Le 27 octobre 2020, l’Autorité des marchés financiers a annoncé la réouverture de l’offre publique d’achat amicale visant les actions IntegraGen, du 30 octobre au 12 novembre 2020, suite au succès de la première offre, clôturée le 21 octobre 2020, à l’issue de laquelle la Société belge OncoDNA détient 3.897.110 actions IntegraGen, représentant 58,92% du capital et des droitsWhen Will IntegraGen SA (EPA:ALINT) Turn A Profit?
IntegraGen SA's (EPA:ALINT): IntegraGen SA engages in the genome analysis, and development and commercialization of...IntegraGen and Advanced Biological Laboratories Sign Global Licensing Agreement for the Commercialization of miRpredX Test
IntegraGen, a company specializing in the transformation of data from biological samples into genomic information and diagnostic tools for oncology, and Advanced Biological Laboratories (ABL), a leading integrated diagnostics and medical IT company, announced today the signing of a non-exclusive global licensing agreement enabling ABL to distribute miRpredX™, IntegraGen’s proprietary IVD CE marked diagnostic test that enables clinicians to identify metastatic colorectal cancer patients who have
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding IntegraGen
Sign Up For FreeTo access detailed company insights
IntegraGen, founded in 2000, is a biotechnology company specializing in the genomics of cancer and rare genetic diseases. As part of the OncoDNA group, IntegraGen is a leading provider of DNA sequencing services and genomic data interpretation software. The company operates one of the largest next-generation sequencing laboratories in France and co... Read More
